Advertisement

Analytical and Bioanalytical Chemistry

, Volume 399, Issue 7, pp 2309–2311 | Cite as

Analytical challenges in nanomedicine

  • Christine Kranz
  • Douglas C. Eaton
  • Boris MizaikoffEmail author
Editorial

Nanomedicine is a rapidly developing interdisciplinary research area bridging biology, medicine, engineering, chemistry, material science, and nanotechnology. In recent years, nanotechnology has developed an increasing impact on medical research and practice by taking advantage of the unique properties and dimensions of nanoscale materials, structures, and devices. New approaches applying nanotechnology in medicine are continuously being discovered and range from the localized application of therapeutics via nanoparticles to single molecule detection at the cellular level. Hence, the emerging research area of nanomedicine focuses on nanoscale science and technology facilitating the diagnosis, treatment, and prevention of disease and traumatic injury, the relief of pain, and the preservation and improvement of human health utilizing molecular level tools providing advanced insight into the associated biological processes.

Consequently, taking advantage of the nanotechnology revolution in the medical sciences requires the development of complementary analytical techniques and methods for probing health relevant biological processes, disease pathologies, and therapeutic progress at a cellular and molecular scale with appropriate spatial and temporal resolution. The importance of this field was recognized by government agencies and institutions such as the Food and Drug Administration USA, which cited nanomedicine as an area of future priority in its 2006 report [1]. Furthermore, large-scale initiatives in this field are supported by the National Institutes of Health in the USA, which funds eight so-called Nanomedicine Development Centers [2] and by the European Union within a variety of initiatives. For example, within the EuroNanoMed Joint Transnational Calls in 2009 and 2010, 17 million Euros of research funding were allocated for research projects in regenerative medicine, diagnostics, and targeted delivery systems taking advantage of nanotechnology; these initiatives will be followed by a third call in 2011. The European Science Foundation has documented the potential benefits of nanomedicine in a series of reports providing a forward perspective on nanomedicine starting in 2003 [3].

However, the emerging field of nanomedicine faces several challenges including the general complexity of biological systems interacting with nanoscale materials and devices, the translation of novel measurement concepts and methods into daily clinical routine, and concerns about the safety, potential toxicity, and efficacy of nanoscale medical devices, diagnostic techniques, and materials [4]. In general, it is evident that the majority of research published under the umbrella of nanomedicine is related to nanoparticles and polymeric drug release, which are probably the topics with the most imminent impact in this field. Currently, there are more than 400 ongoing clinical trials involving nanotechnology; the majority of which are for cancer treatment [5].

A literature search using the keywords “nanomedicine” and “analytical chemistry” reveals that to date only a very small fraction of the published literature addresses not only the needs and challenges, but also the potential research opportunities for analytical sciences in this emerging field [6, 7]. From the analytic chemistry point of view, we may consider individual cells as a measurement compartment with spatial/volume dimensions in the μm–nm/μL–nL range and quantitative molecular dimensions in the mM–nM domain. The localized nature of molecular events within or at cellular compartments (e.g., vesicular processes) or at the cell surface (e.g., exo- or endocytosis) along with the local concentration of the constituents of interest determines the need for quantitative analytical measurements at the submicro- and nanoscale. Yet, the diversity of measurement challenges at these compartments include the small dimensions of the involved samples and volumes, the complex and frequently changing background matrix, potential limitations in the sensitivity and/or discriminatory power of in situ analytical techniques, and their temporal and/or spatial resolution to monitor quantitatively dynamic processes associated with cellular functions. In turn, individual optical/spectroscopic, electrochemical, and surface sensitive analytical techniques have already demonstrated significant potential at the micro- to nanoscopic level enabling the identification of molecular species that are present, their concentration, their location, and—ideally—the kinetics/dynamics of the involved molecular processes.

Beyond the technological barriers, a significant challenge in translating nanoscale methods into medically relevant tools results from the disparity in scientific culture separating medical disciplines from the physical sciences. Traditionally, for example, experts in cellular signaling and signal transduction are well versed in applying biochemical methods and molecular approaches to address biological problems relevant to health sciences. However, based on their background, they may not take immediate advantage of the rapid evolution in chemical, physical, and material sciences facilitating the usage of more sophisticated nanoscale technologies and methods for addressing complex problems within their discipline. In turn, scientists advancing nanotechnology may not be aware of the most pertinent questions and analytical challenges to be addressed in cell physiology or—more generally—in biomedicine.

During the preparation of this special issue, it became evident that it is indeed difficult to identify the current analytical challenges in nanomedicine as a collection of biomedical problems to be solved. The variety of topics addressed by the authors ranging from microelectrode arrays and optical sensing/assay techniques to quantum dots and scanning probe microscopies only provides a snapshot of the available (nano)analytical toolset for investigating cell physiology or disease-relevant pathophysiology at an appropriate temporal and spatial scale. Yet, the early detection of pathological changes at individual cells, cell ensembles or entire tissues via molecular and/or morphological patterns, the detection and tracing of key molecular markers, and the—ideally label-free—analysis of and within sub-cellular compartments remain analytical challenges demanding methods with enhanced sensitivity, improved spatial and temporal resolution, and the discriminatory power for measuring individual species of interest.

The editors would like to thank all of the authors for their excellent and timely contributions and the editorial staff of ABC for their invaluable assistance during the preparation of this special issue.

References

  1. 1.
    Wagner V, Dullaart A, Bock AK, Zweck A (2006) Nat Biotechnol 24:1211–1217CrossRefGoogle Scholar
  2. 2.
  3. 3.
  4. 4.
    Sanhai WR, Sakamoto JH, Canady R, Ferrari M (2008) Nature Nanotechnol 3:242–244CrossRefGoogle Scholar
  5. 5.
    Carmo VA, Ferrari CS, Reis EC, Ramaldes GA, Pereira MA, De Oliveira MC, Cardoso VN (2008) Nucl Med Commun 29:33–38CrossRefGoogle Scholar
  6. 6.
    Thompson M (2004) Analyst 129:671CrossRefGoogle Scholar
  7. 7.
    Durner J (2010) Angew Chem Int Ed 49:1026–1051CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Christine Kranz
    • 1
  • Douglas C. Eaton
    • 2
  • Boris Mizaikoff
    • 1
    Email author
  1. 1.Institute of Analytical and Bioanalytical ChemistryUniversity of UlmUlmGermany
  2. 2.Department of PhysiologyEmory University School of MedicineAtlantaUSA

Personalised recommendations